Anders Malmström

Title: Innovations by Anders Malmström in Labor Treatment

Introduction

Anders Malmström is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of obstetrics through his innovative patents. With a total of 4 patents, Malmström's work focuses on improving labor outcomes for pregnant women.

Latest Patents

Malmström's latest patents include groundbreaking methods for treating protracted labor in pregnant women. One of his inventions involves the use of sulfated glycosaminoglycans to establish effective labor. This method comprises administering a depolymerized low molecular weight heparin treated with periodate to eradicate antithrombin III binding affinities. The treatment exhibits an anticoagulant activity of 10 BP units/mg or less and an average molecular weight not higher than 10,000 Da. This innovative approach aims to prime or curatively treat the cervix and myometrium, addressing slow progress of labor. Another patent focuses on the prophylactic priming or curative treatment of the cervix and myometrium, utilizing the same depolymerized low molecular weight heparin to establish effective labor in pregnant women.

Career Highlights

Malmström is associated with Dilafor AB, a company dedicated to advancing medical treatments. His work has garnered attention for its potential to improve maternal and fetal health during labor.

Collaborations

Malmström collaborates with Gunvor Ekman-Ordeberg, a fellow expert in the field. Their partnership enhances the research and development of innovative solutions for labor-related challenges.

Conclusion

Anders Malmström's contributions to obstetrics through his patents represent a significant advancement in labor treatment. His innovative methods have the potential to improve outcomes for pregnant women, showcasing the importance of research and development in this critical area of healthcare.